ZIVO Bioscience (ZIVO) Short Interest Ratio & Short Volume

Short interest is the volume of ZIVO Bioscience shares that have been sold short but have not yet been covered or closed out. As of November 15th, investors have sold 57,700 shares of ZIVO short. 4.24% of ZIVO Bioscience's shares are currently sold short. Learn More on ZIVO Bioscience's current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ZIVO shares currently have a short interest ratio of 4.0. Learn More on ZIVO Bioscience's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 4.24% of ZIVO Bioscience's floating shares are currently sold short.

ZIVO Bioscience saw a increase in short interest during the month of November. As of November 15th, there was short interest totaling 57,700 shares, an increase of 62.5% from the previous total of 35,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

ZIVO Bioscience currently has issued a total of 2,800,000 shares. Some of ZIVO Bioscience's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. ZIVO Bioscience currently has a public float of 1,360,000 shares.

4.24% of ZIVO Bioscience's shares are currently sold short. Here is how the short interest of companies in the industry of "biological products, except diagnostic" compare to ZIVO Bioscience: Evaxion Biotech A/S (0.92%), Aptose Biosciences Inc. (0.59%), Pluri Inc. (0.91%), PharmaCyte Biotech, Inc. (0.24%), Surrozen, Inc. (1.89%), MiNK Therapeutics, Inc. (0.49%), Achilles Therapeutics plc (0.10%), Senti Biosciences, Inc. (0.60%), Protara Therapeutics, Inc. (4.35%), Coeptis Therapeutics Holdings, Inc. (0.66%),

As of the most recent reporting period, the following stocks had the largest short interest positions: RTX Co. ($7.24 billion), T-Mobile US, Inc. ($4.02 billion), Charter Communications, Inc. ($3.72 billion), Occidental Petroleum Co. ($2.80 billion), Lululemon Athletica Inc. ($2.48 billion), Coinbase Global, Inc. ($2.38 billion), Tractor Supply ($2.35 billion), Rivian Automotive, Inc. ($1.79 billion), Royal Caribbean Cruises Ltd. ($1.73 billion), and Moderna, Inc. ($1.71 billion). View all of the most shorted stocks.

Short selling ZIVO is an investing strategy that aims to generate trading profit from ZIVO Bioscience as its price is falling. ZIVO shares are trading up $0.10 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for ZIVO Bioscience occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ZIVO, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ZIVO, twice per month. The most recent reporting period available is November, 15 2023.